Hellowell is a healthcare academic who specialises in PPPs, evaluating their performance around the world, consulting with development agencies and acting as a special adviser to the Health Select Committee in the British House of Commons. He also lectures on healthcare reform to a diverse group of postgraduate students, many of them from developing countries. We talk to him about the role private healthcare companies can, and are, playing in the developing and developed worlds, the future for PPPs, and whether they are “a good thing”.